Opaleye Management Inc.'s Form 4/A amendment
AmendedGrace Therapeutics, Inc. (GRCE) · filed Oct 1, 2026
- Accession no.
- 0001493152-26-045347
- Filed
- Oct 1, 2026, 4:05 PM ET
- Trade date
- Sep 21-23, 2026
- Filing delay
- 10 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Sep 23, 2026
This filing lists 2 non-derivative transactions. Open-market purchases total $31.7K. It was filed 10 days after the trade.
This amendment replaces 0001493152-26-043996 (filed Sep 23, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +9,771 | $2.10 | +$20,519.1 | 2,785,000 | Indirect | |
| Sep 23, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +5,318 | $2.10 | +$11,167.8 | 2,790,318 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- F2
Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Remarks
This Form 4/A is being filed to correct the amount of securities beneficially owned following the reported transactions in Column 5 of Table I, which was inadvertently misstated in the original Form 4 filed on 09/23/2026.